Outcome of hypovascular hepatic nodules revealing no gadoxetic acid uptake in patients with chronic liver disease
Open Access
- 23 May 2011
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 34 (1), 88-94
- https://doi.org/10.1002/jmri.22630
Abstract
Purpose: To elucidate the natural history of hypovascular nodules that appear hypointense on hepatocyte‐phase gadoxetic acid‐enhanced MR images by focusing on hypervascularization over time. Materials and Methods: In this study, 135 hypovascular nodules revealing no gadoxetic acid uptake in 53 patients were examined. All nodules were retrospectively examined using serial follow‐up computed tomography (CT) and MRI examinations until hypervascularity was observed on arterial‐phase dynamic CT or gadoxetic acid‐enhanced MR images, or on CT during hepatic arteriography. Logistic regression analysis was used to investigate the association between hypervascularization and MR findings including a presence of fat assessed by a signal drop on opposed‐phase T1‐weighted images. Results: Of the 135 nodules, 16 underwent hypervascularization. The size of the nodules and the presence of fat in the nodules were independent indicators of hypervascularization. The 1‐year cumulative risk of hypervascularization was 15.6%. This risk was significantly increased in the case of nodules >10 mm (37.6%, P < 0.01) and fat‐containing nodules (26.5%, P < 0.01). Conclusion: Hypovascular nodules that appear hypointense on hepatocyte‐phase gadoxetic acid‐enhanced MR images may progress to conventional hypervascular hepatocellular carcinoma. Nodules more than 10 mm in diameter and containing fat are at high risk for developing hypervascularization. J. Magn. Reson. Imaging 2011;.Keywords
This publication has 30 references indexed in Scilit:
- Distinguishing Hypervascular Pseudolesions of the Liver from Hypervascular Hepatocellular Carcinomas with Gadoxetic Acid–enhanced MR ImagingRadiology, 2010
- Enhancement of liver parenchyma after injection of hepatocyte‐specific MRI contrast media: A comparison of gadoxetic acid and gadobenate dimeglumineJournal of Magnetic Resonance Imaging, 2010
- Liver parenchymal enhancement of hepatocyte‐phase images in Gd‐EOB‐DTPA‐enhanced MR imaging: Which biological markers of the liver function affect the enhancement?Journal of Magnetic Resonance Imaging, 2009
- Hypervascular Focus in the Nonhypervascular Nodule ("Nodule-in-Nodule") on Dynamic Computed TomographyJournal of Computer Assisted Tomography, 2009
- CT Imaging of Early Hepatocellular Carcinoma and the Natural Outcome of Hypoattenuating Nodular Lesions in Chronic Liver DiseaseOncology, 2007
- Enhancement patterns and signal-intensity characteristics of small hepatocellular carcinoma in cirrhosis: pathologic basis and diagnostic challengesEuropean Radiology, 2007
- Management of hepatocellular carcinomaHepatology, 2005
- Diagnosis of small hepatocellular carcinomaHepatology, 2005
- Early advanced hepatocellular carcinoma: evaluation of CT and MR appearance with pathologic correlation.Radiology, 1994
- Early stages of multistep hepatocarcinogenesis: Adenomatous hyperplasia and early hepatocellular carcinomaHuman Pathology, 1991